ANWPX
Price
$76.35
Change
+$0.72 (+0.95%)
Updated
Aug 21 closing price
Net Assets
165.87B
GLVAX
Price
$86.33
Change
+$0.31 (+0.36%)
Updated
Aug 21 closing price
Net Assets
562.65M
Interact to see
Advertisement

ANWPX vs GLVAX

ANWPX vs GLVAX Comparison Chart in %
View a ticker or compare two or three
VS
ANWPX vs. GLVAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANWPX is a StrongBuy and GLVAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ANWPX has more cash in the bank: 166B vs. GLVAX (563M). ANWPX pays higher dividends than GLVAX: ANWPX (0.98) vs GLVAX (0.00). ANWPX was incepted earlier than GLVAX: ANWPX (53 years) vs GLVAX (19 years). GLVAX (1.23) is less costly to investors than ANWPX (0.71). ANWPX is a more actively managed with annual turnover of: 23.00 vs. GLVAX (17.00). ANWPX (6%) and GLVAX (6%) have equivalent initial investment costs. ANWPX has a lower initial minimum investment than GLVAX: ANWPX (250) vs GLVAX (1000). ANWPX annual gain was more profitable for investors over the last year : 8.89 vs. GLVAX (1.98). ANWPX return over 5 years is better than : 16.02 vs. GLVAX (2.60).
ANWPXGLVAXANWPX / GLVAX
Total Expense Ratio0.711.2358%
Annual Report Gross Expense Ratio0.711.2358%
Fund Existence53 years19 years-
Gain YTD8.1299.58485%
Front Load6%6%105%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets166B563M29,485%
Annual Yield % from dividends0.980.00-
Returns for 1 year8.891.98448%
Returns for 3 years44.2444.08100%
Returns for 5 years16.022.60615%
Returns for 10 years109.90106.93103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCA429.1922.92
+5.64%
HCA Healthcare
IMTX8.930.38
+4.44%
Immatics NV
PNNT3.730.05
+1.36%
Pennant Investment Corp
GGRP0.93N/A
N/A
Glimpse Group Inc (The).
CORZ17.81-0.58
-3.15%
Core Scientific